|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Ionis Pharmaceuticals (NASDAQ: IONS) through any online brokerage.
The latest price target for Ionis Pharmaceuticals (NASDAQ: IONS) was reported by Morgan Stanley on October 12, 2021. The analyst firm set a price target for 31.00 expecting IONS to rise to within 12 months (a possible 1.84% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Ionis Pharmaceuticals (NASDAQ: IONS) is $30.44 last updated Fri Oct 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Ionis Pharmaceuticals.
Ionis Pharmaceuticals’s $Q3 earnings are confirmed for after-market on $November 3, 2021.
There is no upcoming split for Ionis Pharmaceuticals.
Ionis Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.